Stage IIIA-N2 non-small-cell lung cancer: from 'surprise' involvement to surgical nightmare

被引:11
|
作者
Van Schil, Paul E. [1 ]
机构
[1] Univ Antwerp Hosp, Dept Thorac & Vasc Surg, Wilrijkstr 10, B-2650 Antwerp, Belgium
关键词
Non-small-cell lung cancer; Stage IIIA; Staging; Restaging; Chemoradiation; Surgery; RANDOMIZED CONTROLLED-TRIAL; INDUCTION CHEMOTHERAPY; PHASE-III; RADIOTHERAPY; SURGERY; RESECTION; N2;
D O I
10.1093/ejcts/ezv457
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1613 / 1614
页数:2
相关论文
共 50 条
  • [21] Optimal Adjuvant Therapy in Resected Stage IIIA-N2 Non-Small-Cell Lung Cancer Harboring EGFR Mutations
    Wen, Miaomiao
    Wang, Lei
    Wang, Xuejiao
    Yang, Sanhu
    Sun, Ying
    Xia, Jinghua
    Zhang, Yanning
    Zhang, Zhipei
    Huang, Lijun
    Jiang, Tao
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (12) : 686 - 693
  • [22] Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival
    Decaluwe, Herbert
    De Leyn, Paul
    Vansteenkiste, Johan
    Dooms, Christophe
    Van Raemdonck, Dirk
    Nafteux, Philippe
    Coosemans, Willy
    Lerut, Toni
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2009, 36 (03) : 433 - 439
  • [23] Variability in the Treatment of Elderly Patients with Stage IIIA (N2) Non-Small-Cell Lung Cancer
    Berry, Mark F.
    Worni, Mathias
    Pietrobon, Ricardo
    D'Amico, Thomas A.
    Akushevich, Igor
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (06) : 744 - 752
  • [24] Neoadjuvant treatment followed by surgery versus definitive chemoradiation in stage IIIA-N2 non-small-cell lung cancer: A multi-institutional study by the oncologic group for the study of lung cancer (Spanish Radiation Oncology Society)
    Counago, F.
    Rodriguez de Dios, N.
    Montemuino, S.
    Jove-Teixido, J.
    Martin, M.
    Calvo-Crespo, P.
    Lopez-Mata, M.
    Samper-Ots, M. P.
    Lopez-Guerra, J. L.
    Garcia-Canibano, T.
    Diaz-Diaz, V
    de Ingunza-Baron, L.
    Murcia-Mejia, M.
    Alcantara, P.
    Corona, J.
    Puertas, M. M.
    Chust, M.
    Couselo, M. L.
    del Cerro, E.
    Moradiellos, J.
    Amor, S.
    Varela, A.
    Thuissard, I. J.
    Sanz-Rosa, D.
    Taboada, B.
    LUNG CANCER, 2018, 118 : 119 - 127
  • [25] Risk Associated with Bilobectomy after Neoadjuvant Concurrent Chemoradiotherapy for Stage IIIA-N2 Non-small-cell Lung Cancer
    Cho, Jong Ho
    Kim, Jhingook
    Kim, Kwhanmien
    Shim, Young Mog
    Kim, Hong Kwan
    Choi, Yong Soo
    WORLD JOURNAL OF SURGERY, 2012, 36 (05) : 1199 - 1205
  • [26] Multimodality therapy in subclassified stage IIIA-N2 non-small cell lung cancer patients according to the Robinson classification: heterogeneity and management
    Hofmann, Hans-Stefan
    Braess, Jan
    Leipelt, Susanne
    Allgaeuer, Michael
    Klinkhammer-Schalke, Monika
    Szoeke, Tamas
    Grosser, Christian
    Pfeifer, Michael
    Ried, Michael
    JOURNAL OF THORACIC DISEASE, 2018, 10 (06) : 3585 - 3594
  • [27] Local treatment of stage IIIA-N2 nonsmall cell lung cancer: surgery and/or radiotherapy
    Van Meerbeeck, Jan P.
    De Pooter, Christel
    Raskin, Jo
    Janssens, Annelies
    Van Schil, Paul E. Y.
    CURRENT OPINION IN ONCOLOGY, 2020, 32 (01) : 54 - 62
  • [28] Surgical Management of Stage IIIA Non-small Cell Lung Cancer
    Toubat, Omar
    Kim, Anthony W.
    CURRENT PULMONOLOGY REPORTS, 2020, 9 (04) : 151 - 163
  • [29] Postoperative Radiotherapy for Resected Stage IIIA-N2 Non-small-cell Lung Cancer: a Review of Outcomes
    Lam, Y. T.
    Lim, F. M. Y.
    Tong, M.
    Cheng, A. C. K.
    HONG KONG JOURNAL OF RADIOLOGY, 2018, 21 (04): : 241 - 248
  • [30] Adjuvant therapy in stage IIIA-N2 non-small cell lung cancer after neoadjuvant concurrent chemoradiotherapy followed by surgery
    Shin, Sumin
    Kim, Hong Kwan
    Cho, Jong Ho
    Choi, Yong Soo
    Kim, Kwhanmien
    Kim, Jhingook
    Zo, Jae Ill
    Sun, Jong-Mu
    Ahn, Myung-Ju
    Park, Keunchil
    Pyo, Hongryull
    Ahn, Yong Chan
    Shim, Young Mog
    JOURNAL OF THORACIC DISEASE, 2020, 12 (05) : 2602 - 2613